Deoxycorticosterone Excretion in Normal, Hypertensive and Hypokalaemic Subjects

1975 ◽  
Vol 48 (2) ◽  
pp. 97-105 ◽  
Author(s):  
C. L. Cope ◽  
S. Loizou

1. Radioimmunoassay has been used to detect and estimate the urinary excretion of deoxycorticosterone (DOC) in normal, hypertensive and hypokalaemic subjects. The range of excretions in ten healthy normal subjects was 41–232 pmol (13.7–76.7 ng) daily, with a mean of 124 pmol (41 ng). 2. In fourteen subjects with essential hypertension without metabolic disturbance the range found was 29–144 pmol (9.7–47.7 ng) daily, with a mean of 87 pmol (28.8 ng), which is not significantly different from that in normal subjects. 3. In twelve patients with Cushing's syndrome due to adrenal cortical hyperplasia the range found was 26–542 pmol (8.7–179 ng). Ten of these twelve patients had values within normal limits. 4. Of nine subjects showing hypokalaemia, eight had elevated excretion of deoxycorticosterone with values from 263 to 5515 pmol (87–1820 ng) daily. Seven of these were hypertensive and two were normotensive. The elevated excretion of deoxycorticosterone found in hypokalaemic subjects is thus not confined to those with hypertension. 5. No correlation has been found between excretion rates for aldosterone and deoxycorticosterone. Raised excretion of the latter provides an indicator of disturbed adrenal cortical metabolism.

1969 ◽  
Vol 60 (1) ◽  
pp. 13-35 ◽  
Author(s):  
Ludwig Kornel

ABSTRACT As an extension of our study on corticosteroid metabolism in essential hypertension, plasma levels of »free«, »polar free«, glucuronide and sulfate conjugated 17-hydroxycorticosteroids (17-OHCS), as well as »total conjugated« 17-OHCS, have been determined in 13 patients with Cushing's syndrome and 56 healthy people, before and after administration of corticotrophin (ACTH). Levels of these steroid fractions were also compared in normal subjects during rest and after intensive work. Furthermore, kinetics of the formation and disposal of each of these steroid fractions were investigated in vivo in 3 normal subjects and 3 patients with Cushing's syndrome, by means of radioisotopic tracer techniques. The results obtained indicated the following: (1) although mean levels of each of the estimated 17-OHCS fractions, both before and after ACTH, were in Cushing's syndrome statistically significantly higher than in normal subjects (exception: 17-OHCS-sulfates after ACTH), many individual values for steroid concentrations in Cushing patients were well below the upper limit of the normal range; (2) levels of conjugated and »polar free« 17-OHCS in these patients were much more often increased above the normal range than those of »free« steroids usually measured; moreover, levels of these steroids in the control specimens constituted a much better index of adrenocortical hyperactivity than those after ACTH administration; (3) arithmetical formulae were construed, taking into account both an absolute increase in steroid levels and a relative increase in levels of conjugated and »polar free« steroids above those of »free« 17-OHCS, which permitted a clear-cut separation of all patients with Cushing's syndrome from normal subjects; (4) in the sulfate conjugated 17-OHCS fraction in Cushing patients, the increase in levels of more polar steroids (extractable with ethyl acetate following solvolysis and removal of less polar steroids with dichloromethane) was statistically significantly greater than that of less polar steroids (extractable with dichloromethane), thus, patients with Cushing's syndrome resembled from this angle patients with essential hypertension; (5) when steroid levels in normal subjects were compared during rest and during intensive work, a proportional increase in all steroid fractions during work was noted; this points to a perfect homeostatic mechanism involving enzyme systems metabolizing cortisol under »normal« stressful conditions; (6) however, after ACTH administration, the increase in the levels of conjugated steroids in normal subjects considerably exceeded that of »free« 17-OHCS; in contrast, in Cushing patients the increase in the conjugated 17-OHCS after ACTH administration was relatively smaller than that of »free« 17-OHCS; this, it is believed, indicates that the level of activity of enzymes metabolizing cortisol is in patients with Cushing's syndrome closer to the upper limit of these enzymes' capacity than in normal subjects, possibly due to a chronic saturation with higher steroid concentrations; (7) the results of the radioisotopic tracer study of the kinetics of formation and disposal of various free and conjugated plasma corticosteroid fractions demonstrated that, under basal conditions: (a) biological halflife of cortisol in Cushing patients is shorter than in normal subjects, (b) rates of formation of conjugated and polar free metabolites are much faster in Cushing patients than in normal subjects; this indicates that patients with Cushing's syndrome develop adaptive mechanisms to metabolize chronically increased loads of cortisol, and explains why plasma levels of »polar free« and conjugated 17-OHCS are a better index of adrenocortical hyperactivity than those of the »free« steroids, usually measured.


1986 ◽  
Vol 32 (1) ◽  
pp. 93-96 ◽  
Author(s):  
M Schöneshöfer ◽  
B Weber ◽  
W Oelkers ◽  
K Nahoul ◽  
F Mantero

Abstract To evaluate their potential usefulness in the differential diagnosis of Cushing's syndrome, we estimated the urinary excretion rates of the following non-metabolized, unbound steroid hormones: pregnenolone, progesterone, 17-OH-pregnenolone, 17-OH-progesterone, dehydroepiandrosterone (DHEA), androstenedione, testosterone, dihydrotestosterone, 11-deoxycorticosterone, 11-deoxycortisol, corticosterone, cortisol, 18-OH-11-deoxycorticosterone, 18-OH-corticosterone, and aldosterone. These were measured in normal subjects and in patients with Cushing's disease, adrenal adenoma, or ectopic corticotropin syndrome. We used "high-performance" liquid chromatography and subsequent radioimmunoassay. Our results indicate that simultaneous estimation of urinary free cortisol and DHEA may be useful in differential diagnosis of hypercorticoid states due to adrenal adenoma and Cushing's disease.


1971 ◽  
Vol 67 (2) ◽  
pp. 303-315 ◽  
Author(s):  
A. J. Moolenaar ◽  
A. P. van Seters

ABSTRACT The 17-oxosteroids were estimated in the urine of 27 patients with Cushing's syndrome by gas-liquid chromatography (G. L. C.). The values of the various steroid fractions are compared with those of normal subjects, patients with thyrotoxicosis and obese subjects. The effect of the age of the patients on the diagnostic value of the invidual 17-oxosteroids and their ratios is discussed.


1969 ◽  
Vol 61 (2) ◽  
pp. 219-231 ◽  
Author(s):  
V. H. Asfeldt

ABSTRACT This is an investigation of the practical clinical value of the one mg dexamethasone suppression test of Nugent et al. (1963). The results, evaluated from the decrease in fluorimetrically determined plasma corticosteroids in normal subjects, as well as in cases of exogenous obesity, hirsutism and in Cushing's syndrome, confirm the findings reported in previous studies. Plasma corticosteroid reduction after one mg of dexamethasone in cases of stable diabetes was not significantly different from that observed in control subjects, but in one third of the insulin-treated diabetics only a partial response was observed, indicating a slight hypercorticism in these patients. An insufficient decrease in plasma corticosteroids was observed in certain other conditions (anorexia nervosa, pituitary adenoma, patients receiving contraceptive or anticonvulsive treatment) with no hypercorticism. The physiological significance of these findings is discussed. It is concluded that the test, together with a determination of the basal urinary 17-ketogenic steroid excretion, is suitable as the first diagnostic test in patients in whom Cushing's syndrome is suspected. In cases of insufficient suppression of plasma corticosteroids, further studies, including the suppression test of Liddle (1960), must be carried out.


1969 ◽  
Vol 60 (4) ◽  
pp. 705-711 ◽  
Author(s):  
A. D. Wright ◽  
G. F. Joplin

ABSTRACT A simple clinical method of determining the skin-fold thickness on the dorsum of the hand has been described using the Harpendon spring-loaded caliper. A normal range for age and sex has been established in 258 normal subjects. The mean skin-fold thickness was greater in men than in women, and in both decreased with age, falling from 2.85 to 1.75 mm in men, and from 2.65 to 1.60 mm in women (aged 15–20 to 70–80). In 48 acromegalic patients, 71 % of the skin-fold measurements were abnormally thick. In 12 patients with Cushing's syndrome, although all measurements were below the normal mean, 42 % only were abnormally thin.


1966 ◽  
Vol 51 (2) ◽  
pp. 166-174 ◽  
Author(s):  
H. Bethge ◽  
W. Winkelmann ◽  
H. Zimmermann

ABSTRACT Four patients with Cushing's syndrome associated with adrenal hyperplasia were submitted to insulin-induced liypoglycaemia. It was shown that contrary to conditions in normal subjects the Cushing-patients failed to respond to hypoglycaemia with an increase of corticosteroids in plasma. This effect was independent of the initial value of corticoid level. It is concluded that pituitary ACTH-release during hypoglycaemia in patients with Cushing's syndrome did not markedly increase. The findings are discussed under the aspects of primary hypothalamic pathogenesis of Cushing's syndrome: ACTH-secretion and plasma level are constant throughout the day and widely independent from exogenous and endogenous influences including such a stressful stimulus as hypoglycaemia.


1978 ◽  
Vol 55 (s4) ◽  
pp. 363s-366s ◽  
Author(s):  
K. Abe ◽  
M. Yasujima ◽  
N. Irokawa ◽  
M. Seino ◽  
S. Chiba ◽  
...  

To investigate the role of renal vasoactive substances in the pathogenesis of essential hypertension, urinary prostaglandin E excretion, urinary kallikrein excretion, plasma renin activity, plasma aldosterone concentration and urinary Na excretion were measured in normal subjects and patients with essential hypertension after stimulation of the renin—angiotensin—aldosterone system by the intravenous injection of frusemide or a low Na diet; after the inhibition of renin—angiotensin—aldosterone by an angiotensin II antagonist and after the inhibition of renal prostaglandin E synthesis by indomethacin. The urinary excretions of prostaglandin E and kallikrein, plasma renin activity and plasma aldosterone concentration increased after frusemide administration. The urinary excretion of kallikrein increased after frusemide or a low Na diet but decreased after the angiotensin II antagonist and indomethacin during Na depletion. Changes in urinary kallikrein excretion paralleled those in the renin—angiotensin—aldosterone system after various stimuli. The urinary excretion of prostaglandin E increased after frusemide. However, a dissociation between the urinary excretions of prostaglandin E and kallikrein was found during the low Na diet: the former decreased and the latter increased. The urinary excretion of prostaglandin E was closely related to urinary Na output after various stimuli. Basal levels of urinary prostaglandin E and kallikrein excretion were lower in essential hypertension than in normal subjects. The release of renal prostaglandin E and kallikrein after frusemide was also suppressed in essential hypertension compared with that in normal subjects. The data indicate that renal kallikrein—kinin and renin—angiotensin—aldosterone may interact in a dynamic fashion to maintain blood pressure, that renal prostaglandin E may be involved in renal Na handling and that the suppression of renal kallikrein—kinin and prostaglandin E in essential hypertension may be an etiological factor in essential hypertension.


1962 ◽  
Vol 40 (2) ◽  
pp. 247-253 ◽  
Author(s):  
M. L. Batrinos ◽  
B. Mathieu de Fossey ◽  
P. Aubert

ABSTRACT The functional capacity of the adrenals was studied in eight adult patients with gonadal dysgenesis, ranging in age from 16–42 years, by measuring the 24-hour urinary excretion of 17-hydroxycorticosteroids (17-OHCS) and of 17-ketosteroids (17-KS) with the patient at rest and also by estimating its response to stimulation with corticotrophin and chorionic gonadotrophin. In six patients the clinical diagnosis of the syndrome was confirmed by laparotomy, when no gonads were found in five patients and a white fibrous band replacing the gonads was found in the other. The remaining two patients of the series both had male sex-chromatin. The resting excretion of both 17-OHCS and 17-KS was within normal limits in all eight patients. After corticotrophin stimulation (25 IU infused over 8 hours) an increased 17-OHCS excretion was found in all patients but the increase was less constant for the 17-KS. These results are identical with those expected from normal subjects and were considered to indicate a normal adrenal secretory capacity in the present cases. Stimulation by chorionic gonadotrophin (HCG test) was performed in four patients using various doses of the hormone, namely 1500 IU for 5 days, 5000 IU for 2 or 5 days, or 10 000 IU for 2 days. Three of these patients had no gonads and the fourth had male sex-chromatin. The HCG test failed to elicit an increased excretion of either 17-OHCS or 17-KS in these patients. This absence of response is regarded as evidence that HCG does not stimulate adrenal tissue to secrete the precursors of these hormones. The findings of the present study are discussed in the light of previous publications.


Sign in / Sign up

Export Citation Format

Share Document